The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

被引:0
|
作者
Madreseh, Elham [1 ,2 ]
Mahmoudi, Mahmood [1 ]
Toosi, Mohssen Nassiri [3 ]
Abolghasemi, Jamileh [4 ]
Zeraati, Hojjat [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[4] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
来源
关键词
Cirrhosis; life expectancy; model for end-stage liver disease; survival; LONG-TERM SURVIVAL; WAITING-LIST; LIFE EXPECTANCY; MELD; RECIPIENTS; CIRRHOSIS; SCORE; BENEFIT; HEALTH; STATES;
D O I
10.4103/jrms.jrms_1091_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.Materials and Methods: In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.Results: With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.Conclusion: The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Model for End-stage Liver Disease
    Singal, Ashwani K.
    Kamath, Patrick S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (01) : 50 - 60
  • [22] Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease
    Sarmast, Naveed
    Ogola, Gerald O.
    Kouznetsova, Maria
    Leise, Michael D.
    Bahirwani, Ranjeeta
    Maiwall, Rakhi
    Tapper, Elliot
    Trotter, James
    Bajaj, Jasmohan S.
    Thacker, Leroy R.
    Tandon, Puneeta
    Wong, Florence
    Reddy, K. Rajender
    O'Leary, Jacqueline G.
    Masica, Andrew
    Modrykamien, Ariel M.
    Kamath, Patrick S.
    Asrani, Sumeet K.
    HEPATOLOGY, 2020, 72 (05) : 1747 - 1757
  • [23] Risk factors for osteoporosis in patients with end-stage liver disease
    Uchida, Shinjiro
    Miyaaki, Hisamitsu
    Ichikawa, Tatsuki
    Taura, Naota
    Miuma, Satoshi
    Honda, Takuya
    Shibata, Hidetaka
    Haraguchi, Masafumi
    Senoo, Takemasa
    Nakao, Kazuhiko
    BIOMEDICAL REPORTS, 2016, 5 (05) : 629 - 633
  • [24] Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
    Kim, Jeong Han
    Cho, Yong Joon
    Choe, Won Hyeok
    Kwon, So Young
    Yoo, Byung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02): : 248 - 260
  • [25] Association of nonstandardized model for end-stage liver disease score exceptions with waitlist mortality in adult liver transplant candidates
    Ahn, Daniel J.
    Kwong, Allison J.
    Wall, Anji E.
    Parker, William F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (02) : 385 - 395
  • [26] Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality
    Ben-Haim, Menahem
    Carmiel, Michal
    Katz, Paulina
    Shabtai, Esther
    Oren, Ran
    Nakache, Richard
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (09): : 605 - 609
  • [28] Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease
    Sun, Fu-Rong
    Wang, Ying
    Wang, Bing-Yuan
    Tong, Jing
    Zhang, Dai
    Chang, Bing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) : 50 - 54
  • [29] Liver transplantation outcomes under the model for end-stage liver disease and pediatric end-stage liver disease
    Freeman, RB
    Harper, A
    Edwards, EB
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2005, 10 (02) : 90 - 94
  • [30] Psychiatric prognostic factors in patients with alcohol-related end-stage liver disease before liver transplantation
    Roggla, H
    Roggla, G
    Muhlbacher, F
    WIENER KLINISCHE WOCHENSCHRIFT, 1996, 108 (09) : 272 - 275